Advance Planning Is The Key To Avoiding And Surviving Layoffs, Career Experts Say

A survey of 836 United States companies released in September by the New York-based American Management Association found that one in four of them planned layoffs by June of this year. In government, the news is also grim. When President Bush proposed increasing 1993 science spending by 6.5 percent, Congress slashed it to a paltry 2.3 percent, paralyzing budgets at many agencies. And President-elect Bill Clinton's focus on technologies that meet social needs more immediately than does basic res

Written byRicki Lewis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

A survey of 836 United States companies released in September by the New York-based American Management Association found that one in four of them planned layoffs by June of this year.

In government, the news is also grim. When President Bush proposed increasing 1993 science spending by 6.5 percent, Congress slashed it to a paltry 2.3 percent, paralyzing budgets at many agencies. And President-elect Bill Clinton's focus on technologies that meet social needs more immediately than does basic research will affect academia in the form of altered funding priorities.

To a scientist, a layoff may seem to come out of the blue. Still, researchers can plan ahead to avoid this fate, or to deal with it and get back on the career track as quickly and painlessly as possible, job-placement experts agree.

First, The Good News Even though layoffs are sometimes inevitable, retaining scientists is a very high priority at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies